These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2893989)

  • 1. Electrophysiological evidence for a non-opioid interaction between dynorphin and GABA in the substantia nigra of the rat.
    Robertson BC; Hommer DW; Skirboll LR
    Neuroscience; 1987 Nov; 23(2):483-90. PubMed ID: 2893989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of D1 and D2 dopamine receptor agonists on substantia nigra pars reticulata neurons.
    Waszczak BL
    Brain Res; 1990 Apr; 513(1):125-35. PubMed ID: 2140951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological changes in substantia nigra after dynorphin administration.
    Lavin A; Garcia-Munoz M
    Brain Res; 1986 Mar; 369(1-2):298-302. PubMed ID: 2870776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABAergic mechanisms in regulating the activity state of substantia nigra pars reticulata neurons.
    Windels F; Kiyatkin EA
    Neuroscience; 2006 Jul; 140(4):1289-99. PubMed ID: 16713116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of morphine on dynorphin B and GABA release in the basal ganglia of rats.
    You ZB; Herrera-Marschitz M; Nylander I; Goiny M; Kehr J; Ungerstedt U; Terenius L
    Brain Res; 1996 Feb; 710(1-2):241-8. PubMed ID: 8963665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dynorphin (1-8) on movement: non-opiate effects and structure-activity relationship.
    Friederich MW; Friederich DP; Walker JM
    Peptides; 1987; 8(5):837-40. PubMed ID: 2893358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological evidence for kappa-agonist activity of dynorphin in rat brain.
    Brookes A; Bradley PB
    Neuropharmacology; 1984 Feb; 23(2A):207-10. PubMed ID: 6325991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional studies with the opioid peptide dynorphin: acute effects of injections into the substantia nigra reticulata of naive rats.
    Herrera-Marschitz M; Hökfelt T; Ungerstedt U; Terenius L
    Life Sci; 1983; 33 Suppl 1():555-8. PubMed ID: 6141500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of the kappa opiate U50,488 in the substantia nigra pars reticulata.
    Thompson LA; Walker JM
    Brain Res; 1990 May; 517(1-2):81-7. PubMed ID: 2165438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABAergic control of rat substantia nigra dopaminergic neurons: role of globus pallidus and substantia nigra pars reticulata.
    Celada P; Paladini CA; Tepper JM
    Neuroscience; 1999 Mar; 89(3):813-25. PubMed ID: 10199615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of neurotransmitter release by cholecystokinin in the neostriatum and substantia nigra of the rat: regional and receptor specificity.
    You ZB; Herrera-Marschitz M; Pettersson E; Nylander I; Goiny M; Shou HZ; Kehr J; Godukhin O; Hökfelt T; Terenius L; Ungerstedt U
    Neuroscience; 1996 Oct; 74(3):793-804. PubMed ID: 8884775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kappa opiate receptors inhibit release of oxytocin from the magnocellular system during dehydration.
    Summy-Long JY; Rosella-Dampman LM; McLemore GL; Koehler E
    Neuroendocrinology; 1990 Apr; 51(4):376-84. PubMed ID: 1971712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological effects of dynorphin peptides on hippocampal pyramidal cells in rat.
    Moises HC; Walker JM
    Eur J Pharmacol; 1985 Jan; 108(1):85-98. PubMed ID: 2858395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of neurotransmitter release in the basal ganglia of the rat brain by dynorphin peptides.
    You ZB; Herrera-Marschitz M; Terenius L
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1307-15. PubMed ID: 10454508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple opiate receptors may be involved in suppressing gamma-aminobutyrate release in substantia nigra.
    Starr MS
    Life Sci; 1985 Dec; 37(24):2249-55. PubMed ID: 2999545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intranigral injections of dynorphin, dynorphin fragments and alpha-neoendorphin on rotational behaviour in the rat.
    Herrera-Marschitz M; Hökfelt T; Ungerstedt U; Terenius L; Goldstein M
    Eur J Pharmacol; 1984 Jul; 102(2):213-27. PubMed ID: 6148248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action.
    Faden AI; Jacobs TP
    Br J Pharmacol; 1984 Feb; 81(2):271-6. PubMed ID: 6142741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
    Scheurer U; Wenger F; Caliezi A; Drack E; Varga L; Halter F
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1324-30. PubMed ID: 1969475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective activation of 5-HT(2C) receptors stimulates GABA-ergic function in the rat substantia nigra pars reticulata: a combined in vivo electrophysiological and neurochemical study.
    Invernizzi RW; Pierucci M; Calcagno E; Di Giovanni G; Di Matteo V; Benigno A; Esposito E
    Neuroscience; 2007 Feb; 144(4):1523-35. PubMed ID: 17161544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of the opiate mechanisms of the hippocampus and substantia nigra in the behavioral and convulsive disorders in picrotoxin-induced kindling].
    Kryzhanovskiĭ GN; Shandra AA; Godlevskiĭ LS; Mazarati AM; Nguyen TT
    Biull Eksp Biol Med; 1991 Mar; 111(3):235-9. PubMed ID: 1675896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.